Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wakeling

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Cancer Surveys|January 1, 1992
Steroid antagonists as nuclear receptor blockersA E Wakeling
Endocrine-Related Cancer|May 16, 2000
Similarities and distinctions in the mode of action of different classes of antioestrogensA E Wakeling
Biochemical Pharmacology|May 26, 1995
Use of pure antioestrogens to elucidate the mode of action of oestrogensA E Wakeling
Cancer Treatment and Research|January 1, 1991
Regulatory mechanisms in breast cancer. Steroidal pure antiestrogensA E Wakeling
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Steroid and peptide hormones and growth factorsA Howell, A E Wakeling
The Journal of Endocrinology|December 1, 1983
Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogensA E Wakeling, B Valcaccia
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
ICI 182,780, a new antioestrogen with clinical potentialA E Wakeling, J Bowler
Drugs Under Experimental and Clinical Research|January 1, 1988
Biology and mode of action of pure antioestrogensA E Wakeling, J Bowler
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Steroid and peptide hormones and growth factorsA Howell, A E Wakeling
Journal of Steroid Biochemistry|October 1, 1988
Novel antioestrogens without partial agonist activityA E Wakeling, J Bowler
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Cancer Surveys|January 1, 1992
Steroid antagonists as nuclear receptor blockersA E Wakeling
Endocrine-Related Cancer|May 16, 2000
Similarities and distinctions in the mode of action of different classes of antioestrogensA E Wakeling
Biochemical Pharmacology|May 26, 1995
Use of pure antioestrogens to elucidate the mode of action of oestrogensA E Wakeling
Cancer Treatment and Research|January 1, 1991
Regulatory mechanisms in breast cancer. Steroidal pure antiestrogensA E Wakeling
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1988
Steroid and peptide hormones and growth factorsA Howell, A E Wakeling
The Journal of Endocrinology|December 1, 1983
Antioestrogenic and antitumour activities of a series of non-steroidal antioestrogensA E Wakeling, B Valcaccia
The Journal of Steroid Biochemistry and Molecular Biology|September 1, 1992
ICI 182,780, a new antioestrogen with clinical potentialA E Wakeling, J Bowler
Drugs Under Experimental and Clinical Research|January 1, 1988
Biology and mode of action of pure antioestrogensA E Wakeling, J Bowler
Cancer Chemotherapy and Biological Response Modifiers|January 1, 1987
Steroid and peptide hormones and growth factorsA Howell, A E Wakeling
Journal of Steroid Biochemistry|October 1, 1988
Novel antioestrogens without partial agonist activityA E Wakeling, J Bowler
Pageof 9